Type
. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria. Arzneimittel-Forschung. 1981;31(12):2155-7.
Type
. [Studies on M. leprae isolated from the lymph of a lepromatous patient using the freeze-fracture technic]. Revista cubana de medicina tropical. 1981;33(1):13-8.
Type
. Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy. Scandinavian journal of immunology. 1981;13(6):553-62.
Type
. [Problems in designing a protocol for a leprosy vaccine trial. (author's transl)]. Revue d'epidemiologie et de sante publique. 1981;29(3):305-14.
Type
. [Jorge Lobo disease. Study of 22 new cases]. Medicina cutanea ibero-latino-americana. 1981;9(2):87-96.
Type
. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor. Hansenologia internationalis. 1980;5(1):3-27.
Type
. [Maintenance of armadillos in captivity and results of the inoculation of Mycobacterium leprae]. Hansenologia internationalis. 1980;5(1):28-36.
Type
. Leprosy in the United States, 1967-76. Public health reports (Washington, D.C. : 1974) [Internet]. 1978;93(5):468-73. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1431941/pdf/pubhealthrep00140-0066.pdf
Type
. Can the dapsone-creatinine ratio in urine be used to monitor therapy in rural areas?. Leprosy in India. 1978;50(3):485-7.
Type
. Strategy on leprosy control. Leprosy in India. 1978;50(3):418-27.